Article thumbnail

The Staphylococcus aureus RNome and Its Commitment to Virulence

By Brice Felden, François Vandenesch, Philippe Bouloc and Pascale Romby

Abstract

Staphylococcus aureus is a major human pathogen causing a wide spectrum of nosocomial and community-associated infections with high morbidity and mortality. S. aureus generates a large number of virulence factors whose timing and expression levels are precisely tuned by regulatory proteins and RNAs. The aptitude of bacteria to use RNAs to rapidly modify gene expression, including virulence factors in response to stress or environmental changes, and to survive in a host is an evolving concept. Here, we focus on the recently inventoried S. aureus regulatory RNAs, with emphasis on those with identified functions, two of which are directly involved in pathogenicity

Topics: Review
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3053349
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). A rough guide to the non-coding RNA world of Salmonella.
  2. (2009). A search for small noncoding RNAs in Staphylococcus aureus reveals a conserved sequence motif for regulation.
  3. (2010). A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immuneevasion molecule.
  4. (2010). Abundance of type I toxin-antitoxin systems in bacteria: searches for new candidates and discovery of novel families.
  5. (2002). Accessory gene regulator (agr)l o c u si n geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.
  6. (1995). Activation of alphatoxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII.
  7. (2008). agr function in clinical Staphylococcus aureus isolates.
  8. (2002). Antisense RNAs in bacteria and their genetic elements.
  9. (2009). At the crossroads of bacterial metabolism and virulence factor synthesis in Staphylococci.
  10. (2003). Autoinduction and signal transduction in the regulation of staphylococcal virulence.
  11. (2010). Base pairing small RNAs and their roles in global regulatory networks.
  12. (2010). Camilli A
  13. (2010). Cartography of methicillin-resistant S. aureus transcripts: detection, orientation and temporal expression during growth phase and stress conditions.
  14. (2006). Characterization of the Staphylococcus aureus heat shock, cold shock, stringent, and SOS responses and their effects on log-phase mRNA turnover.
  15. (2006). Characterizing the effect of the Staphylococcus aureus virulence factor regulator, SarA, on log-phase mRNA half-lives.
  16. (1988). Cloning of a chromosomal locus (exp) which regulates the expression of several exoprotein genes in Staphylococcus aureus.
  17. (2010). Community-associated meticillin-resistant Staphylococcus aureus.
  18. (2004). Control of gene expression by a natural metabolite-responsive ribozyme.
  19. (2009). Design and antimicrobial action of purine analogues that bind Guanine riboswitches.
  20. (2010). Experimental discovery of small RNAs in Staphylococcus aureus reveals a riboregulator of central metabolism.
  21. (2007). Feedback control of glucosamine-6-phosphate synthase
  22. (2003). Global regulation of Staphylococcus aureus genes by Rot.
  23. (2010). Hfq is a global regulator that controls the pathogenicity of Staphylococcus aureus.
  24. (2010). Identification of differentially expressed small non-protein-coding RNAs in Staphylococcus aureus displaying both the normal and the small-colony variant phenotype.
  25. (2006). Identification of small Hfq-binding RNAs in Listeria monocytogenes.
  26. (2006). Inhibition of rot translation by RNAIII, a key feature of agr function.
  27. (2009). Messenger RNA turnover processes in Escherichia coli, Bacillus subtilis, and emerging studies in Staphylococcus aureus.
  28. (2004). Microarray-based analysis of the Staphylococcus aureus sigmaB regulon.
  29. (2009). Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA.
  30. (2005). New insights into regulation of the tryptophan biosynthetic operon in Gram-positive bacteria.
  31. (2007). No detectable effect of RNA-binding protein Hfq absence in Staphylococcus aureus.
  32. (2009). Novel activities of glycolytic enzymes in Bacillus subtilis: interactions with essential proteins involved in mRNA processing.
  33. (2010). Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways.
  34. (2008). Novel strategies to combat bacterial virulence.
  35. (2009). On the facultative requirement of the bacterial RNA chaperone,
  36. (2010). Operon structure of Staphylococcus aureus.
  37. (2004). Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombininduced platelet microbicidal protein.
  38. (2008). Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains.
  39. (2000). Probing the structure of RNAIII, the Staphylococcus aureus agr regulatory RNA, and identification of the RNA domain involved in repression of protein A expression.
  40. (1989). pT181 plasmid replication is regulated by a countertranscript-driven transcriptional attenuator.
  41. (2008). Quorum sensing in staphylococci.
  42. (1998). Regulation of agr-dependent virulence genes in Staphylococcus aureus by RNAIII from coagulase-negative staphylococci.
  43. (1986). Regulation of exoprotein gene expression in Staphylococcus aureus by agr.
  44. (2007). Regulation of gene expression by small non-coding RNAs: a quantitative view.
  45. (2004). Regulation of transposition in bacteria.
  46. (2009). Regulatory RNAs in bacteria.
  47. (2006). Riboswitches as antibacterial drug targets.
  48. (2008). RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus.
  49. (2011). Searching for small sB-regulated genes in Staphylococcus aureus.
  50. (2009). Single-pass classification of all noncoding sequences in a bacterial genome using phylogenetic profiles.
  51. (2006). Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections.
  52. (2005). Small RNA genes expressed from Staphylococcus aureus genomic and pathogenicity islands with specific expression among pathogenic strains.
  53. (2004). Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes.
  54. (2009). Staphylococcus aureus as an infectious agent: overview of biochemistry and molecular genetics of its pathogenicity.
  55. (2010). Staphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia.
  56. (2010). Staphylococcus aureus nonribosomal peptide secondary metabolites regulate virulence.
  57. (2004). Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1.
  58. (2005). Staphylococcus aureus RNAIII and the endoribonuclease III coordinately regulate spa gene expression.
  59. (2010). Staphylococcus aureus RNAIII binds to two distant regions of coa mRNA to arrest translation and promote mRNA degradation. PLoS Pathog 6:
  60. (2007). Staphylococcus aureus RNAIII coordinately represses the synthesis of virulence factors and the transcription regulator Rot by an antisense mechanism.
  61. (2004). Structural basis for discriminative regulation of gene expression by adenine- and guanine-sensing mRNAs.
  62. (2004). Structure of a natural guanineresponsive riboswitch complexed with the metabolite hypoxanthine.
  63. (2007). Subedi A
  64. (1993). Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule.
  65. (2009). The A-Z of bacterial translation inhibitors.
  66. (2004). The influence of agr and sigmaB in growth phase dependent regulation of virulence factors in Staphylococcus aureus.
  67. (1990). The IS10 transposase mRNA is destabilized during antisense RNA control.
  68. (2009). The Listeria transcriptional landscape from saprophytism to virulence.
  69. (2010). The phage-related chromosomal islands of Gram-positive bacteria.
  70. (2010). The primary transcriptome of the major human pathogen Helicobacter pylory.
  71. (2010). The RNA degradosome in Bacillus subtilis: identification of CshA as the major RNA helicase in the multiprotein complex.
  72. (2010). The role of Hfq in bacterial pathogens.
  73. (2005). Thymidine-dependent Staphylococcus aureus small-colony variants are associated with extensive alterations in regulator and virulence gene expression profiles.
  74. (2010). Tn10/IS10 transposition is downregulated at the level of transposase expression by the RNA-binding protein Hfq.
  75. (2001). Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci.
  76. (2006). Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390.
  77. (2008). Two seemingly homologous noncoding RNAs act hierarchically to activate glmS mRNA translation.
  78. (2009). Waves of resistance: Staphylococcus aureus in the antibiotic era.
  79. (2001). Wholegenome sequencing of meticillin-resistant Staphylococcus aureus.
  80. (2010). Widespread antisense transcription in Escherichia coli. MBio 1: